|
@ΦAYΘwlΘwοο ICW[i |
<< wοΦίι
<< OΜy[WΦίι
ζ106ρwpWοi½¬15N105ϊj
yκΚθz
tEΓΕ DPϊΙΗ΅½[Γ¬πΗΙζθffΙΑ½ζV«AT IIIΉΗΜκα
σo@Cξ, Ό@νΆ, OY@Φ, μ£@’ίq, Rϋ@Ήq, Ίc@mΊ, ΔR@FY, ΰV@ΟΎY, |Ί@rs
ϊ{γΘεwYwlΘ
@ζV«Antithrombin IIIiAT IIIjΉΗΝAT IIIαΊΙζθΓΕ@\΄iσΤ𫽡CνXΜvφΙζθΓ¬nπSΙππ`¬·ινυFΜDΆβ`Ύ³Ε ιD‘ρδXΝDPϊΙ[Γ¬πΗπΗ΅CffΙΑ½ζV«AT IIIΉΗΜκαπo±΅½ΜΕα±ΜΆ£Il@πάΆ¦Δρ·ιDΗαΝ27Ξ1ρoD0ρoYD26ΞCDP7TΕsS¬YΜω θDΖ°πΙΑL·Χ«ΝΘ’D@ΕDPΜfollow upπp±CDP9T6ϊΙΆΊΜ[Γ¬πΗπΗ΅CΈΈΙζθRJWIsRΜIgMlΜγΈCProtein S«ΜαΊCAT III«¨ζΡR΄ΜαΊͺwE³κCAT IIIΉΗtype 1CProtein SΉΗCRΏRΜΗσQΖff΅½D[Γ¬πΗΙΞ΅Δurokinase^ΝsνΈCHeparin CaCAT III»ά^ΙζΑΔπΝΑΈ΅CΘ~ΔβΗσΜ«πFίι±ΖΝΘ©Α½D»Μγp±IΙHeparin CaCAT III»άΜ^¨ζΡΊΓ¬GR[Ιζθfollow upπsΑ½DDPoίΙr
ίΗβIUGRπΝΆίΖ·ιΉΗΜΗΝΘCDP36T5ϊΙOϊj
©ηoδSͺΨΙΑ½DΙO\ο`ΝFίηκΘ©Α½DͺΨγΝAT IIIΑοΜ΄iΙΞ΅ΔHeparin CaCAT III»άΜ^πΌΏΙJn΅CΰΘIfollow upπsΑΔ’ιDζV«ΓΕφqΉά½ΝαΊΗΉΜDwΕΝDPπ_@ΙΗσΜ«πFίι±Ζͺ½C‘ρΜΗαΕΝDPΜ[Γ¬πΗΜΗ©ηRΓΕφqΉΗπ^ΑΔffπiίι±ΖͺΕ«½D
ϊ{YΘwlΘwοΦAnϋοορ, 40(3)
338-338, 2003
|